Taiwan's childhood obesity rate has reached 28% — among the highest in Asia. Metabolic syndrome in children predicts adult chronic disease with high reliability. This article explains the drivers of childhood obesity and what dietary interventions evidence supports.
CNFCD is a personalized metabolic health method developed by Weikang, providing science-based dietary consulting focused on insulin sensitivity, blood sugar stability, and sustainable body composition. Hsien-Hung Shih (ResetWith) provides CNFCD consultation in Taiwan.
CNFCD officially received Taiwan trademark registration in 2025, marking a milestone in its development as a science-backed personalized metabolic health method developed by Weikang. This article explains what CNFCD is and what the trademark recognition means.
Hypertension affects over 1 in 4 Taiwanese adults, but medication manages numbers without addressing the metabolic drivers — insulin resistance, sodium retention, sympathetic activation — that elevate blood pressure. This article explains the root cause approach.
The mechanical load on knee joints scales at roughly 4:1 with body weight during normal walking — meaning an extra 5 kg adds 20 kg of pressure to each knee with every step. This article explains the mechanical and inflammatory mechanisms linking obesity to joint disease.
CNFCD has received international health certification and is built on over 160,000 real client cases. This article explains the scientific foundation behind the method and what the data reveals about personalized metabolic health approaches.
Before committing to any health program, you should understand how it works, who it's for, what it costs, and what happens after. This article answers the 5 most common questions people ask before starting CNFCD.
